Dr. Reddy’s Laboratories has set targets for reduction of emissions as approved by the Science Based Targets initiative (SBTi).

The Hyderabad-based Dr. Reddy’s is committed to achieving Net Zero greenhouse gas emissions across its value chain by FY2045.

In the near term, the company commits to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 80 per cent and Scope 3 emissions by 51.6 per cent per gross profit of the company in Rupee terms by FY2030, using FY2023 as the base year.

In the long term, it commits to reducing absolute Scope 1, 2, and 3 emissions by 90 per cent by FY2045, again from the FY2023 baseline. Dr. Reddy’s is the only company in India’s pharmaceutical sector to commit to a science-based Net Zero target by FY2045.

In October 2020, Dr. Reddy’s announced

See Full Page